All Season Financial Advisors, Inc. Merck & Co., Inc. Transaction History

All Season Financial Advisors, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 01, 2023	SELL	$87.44 - $112.11 $561,714 - $720,194	-6,424 Reduced 36.43%	11,209 $1.24 Million
Q3 2022 Oct 21, 2022	SELL	$84.53 - $94.96 $326,454 - $366,735	-3,862 Reduced 17.97%	17,633 $1.52 Million
Q2 2022 Jul 18, 2022	BUY	$83.49 - $94.64 $324,776 - $368,149	3,890 Added 22.1%	21,495 $1.96 Million
Q1 2022 Apr 29, 2022	BUY	$73.51 - $82.4 $1,690 - $1,895	23 Added 0.13%	17,605 $1.44 Million
Q4 2021 Jan 25, 2022	BUY	$72.28 - $90.54 $939 - $1,177	13 Added 0.07%	17,582 $1.35 Million
Q3 2021 Oct 20, 2021	SELL	$71.68 - $78.83 $364,851 - $401,244	-5,090 Reduced 22.46%	17,569 $1.32 Million
Q2 2021 Jul 21, 2021	BUY	$70.31 - $77.77 $1.59 Million - $1.76 Million	22,659 New	22,659 $1.76 Million

3,820

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $251B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of All Season Financial Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on All Season Financial Advisors, Inc. with notifications on news.